Agenus Names Jean-Marie Cuillerot New Chief Medical Officer

Xconomy Boston — 

Agenus (NASDAQ: AGEN) has appointed Jean-Marie Cuillerot chief medical officer of the immuno-oncology company. Cuillerot joined Cambridge, MA-based Agenus last year as vice president and global head of clinical development. His experience includes roles at Merck Serono and Bristol-Myers Squibb (NYSE: BMY).